| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 4.931 | 32.900 | 54.119 | 63.844 | 83.735 | 100.408 | 99.334 | 84.617 |
| Total Income - EUR | - | 0 | 4.931 | 32.900 | 54.119 | 65.245 | 83.752 | 100.847 | 99.485 | 84.705 |
| Total Expenses - EUR | - | 23 | 91 | 20.951 | 20.293 | 15.006 | 16.762 | 26.124 | 24.686 | 26.198 |
| Gross Profit/Loss - EUR | - | -23 | 4.840 | 11.950 | 33.826 | 50.239 | 66.990 | 74.722 | 74.800 | 58.507 |
| Net Profit/Loss - EUR | - | -23 | 4.692 | 11.621 | 33.285 | 49.621 | 66.152 | 73.711 | 73.806 | 57.662 |
| Employees | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 94 | 60 | 21.974 | 17.311 | 12.744 | 7.930 | 4.134 | 629 | 522 |
| Current Assets | - | 62 | 4.801 | 22.460 | 36.162 | 60.789 | 155.992 | 105.633 | 136.169 | 126.034 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 427 | 7.379 | 9.769 | 20.008 | 29.296 | 22.250 | 12.111 | 1.128 |
| Cash | - | 62 | 4.374 | 15.080 | 26.393 | 40.781 | 126.696 | 83.383 | 124.057 | 124.906 |
| Shareholders Funds | - | 22 | 4.714 | 16.248 | 35.687 | 57.756 | 122.628 | 74.712 | 110.387 | 106.027 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 134 | 148 | 20.030 | 17.955 | 15.777 | 41.294 | 35.054 | 26.410 | 20.529 |
| Income in Advance | - | 0 | 0 | 8.328 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Pmed Srl